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ABSTRACT: Analysis of oxylipins by liquid chromatography mass spectrometry (LC-MS) is challenging because of the small mass 
range occupied by this diverse lipid class, the presence of numerous structural isomers, and their low abundance in biological samples. 
Although highly sensitive LC-MS/MS methods are commonly used, further separation is achievable by using drift tube ion mobility 
coupled with high-resolution mass spectrometry (DTIM-MS). Herein, we present a combined analytical and computational method 
for the identification of oxylipins and fatty acids. We use a reversed-phase LC-DTIM-MS workflow able to profile and quantify 
(based on chromatographic peak area) the oxylipin and fatty acid content of biological samples while simultaneously acquiring full 
scan and product ion spectra. The information regarding accurate mass, collision-cross section values in nitrogen (DTCCSN2) and 
retention times of the species found are compared to an internal library of lipid standards as well as the LIPID MAPS Structure 
Database by using specifically developed processing tools. Features detected within the DTCCSN2 and m/z ranges of the analyzed 
standards are flagged as oxylipin-like species, which can be further characterized using drift time alignment of product and precursor 
ions distinctive of DTIM-MS. This not only helps identification by reducing the number of annotations from LIPID MAPS, but also 
guides discovery studies of potentially novel species. Testing the methodology on Salmonella enterica serovar Typhimurium infected 
murine bone-marrow derived macrophages and thrombin activated human platelets yields results in agreement with literature. This 
workflow has also annotated features as potentially novel oxylipins, confirming its ability in providing further insights into lipid 
analysis of biological samples. 
Oxylipins represent a large network of bioactive lipid media-
tors (Figure S1), possessing both physiological and pathological 
roles.1 These lipids derive from oxidation of polyunsaturated 
fatty acids (PUFA), either enzymatically by cyclooxygenases 
(COXs), lipoxygenases (LOXs) and cytochrome P450s, or non-
enzymatically via free-radical peroxidation processes.1,2 Within 
the class of oxylipins, several isomers can be found which exert 
distinct biological functions and have a different biochemical 
origin. For example, the six isoforms of HETEs can derive from 
oxidation of arachidonic acid either by LOXs (5-, 12- and 15-
HETE) or COXs (11- and 15-HETE), while 8- and 9-HETE de-
rive mostly from non-enzymatic autoxidation. Hence, identifi-
cation of the correct isomers is fundamental to fully understand 
both their path of generation and function. Oxidation products 
of C20 PUFAs such as arachidonic acid are commonly known 
as eicosanoids, which are generated in cells and tissues in re-
sponse to physiological and pathological changes2 and play cru-
cial roles in mediating inflammation and homeostasis as well as 
diseases such as cancer, atherosclerosis and Alzheimer’s.3–5 Ox-
ylipins are either released by cells/tissues to act as free media-
tors, or re-esterified into phospholipids and integrated into the 
cell membrane of platelets and leukocytes where they can inter-
act with coagulation factors or act pro- or anti-inflammatory.6 
Oxylipins are found in low nanomolar concentrations in biolog-
ical samples, therefore their analysis requires highly selective 
and sensitive methods. To achieve this, ultra-high performance 
liquid chromatography (UHPLC) using reversed-phase col-
umns in combination with triple quadrupole mass spectrometers 
coupled with negative electrospray ionization are commonly 
used.7,8 Although this methodology allows both sensitive and 
selective analysis, targeted approaches are time-consuming in 
their development and will miss lipids that are not specifically 
being analyzed. Ion mobility coupled with high-resolution mass 
spectrometry (IM-MS) can be used to achieve more specificity 
in untargeted approaches, allowing measurements of both accu-
rate mass and collision cross-section (CCS) values of the ions 
to provide greater certainty in terms of identification. In recent 
years, IM-MS has developed as an emerging technique in lip-
idomics,9,10 however, oxylipins analysis by IM-MS has been 
limited to some eicosanoids using travelling-wave IM,11,12 leu-
kotrienes and protectins using differential IM,13 and some ox-
ylipins using drift tube IM (DTIM-MS).14 In this study we de-
scribe a comprehensive analytical and computational workflow 
for the analysis of oxylipins and fatty acids (FAs) using 
UHPLC-DTIM-QTOF, in which size and shape of the ions af-
fect their mobility when travelling through a drift tube filled 
 with low pressure nitrogen gas, allowing their separation and 
the calculation of their CCS values for nitrogen (DTCCSN2). An-
notation and identification of oxylipins and FAs was enhanced 
through an extension of the KniMet pipeline for the processing 
of metabolomics data15 with a combined annotation method 
comprising the LIPID MAPS Structure Database (LMSD)16,17 
and an internally generated library containing 47 unique lipids. 
The UHPLC-DTIM-MS method presented in this study also al-
lows quantification of oxylipins in biological samples, and its 
combination with data-independent acquisition enables lipid 
identification based on drift time alignment between diagnostic 
product ions and their precursors. The computational pipeline 
as well as the data obtained for the 47 lipid standards is publicly 
available at https://github.com/sonial/KniMet and could con-
tribute to the creation and expansion of CCS databases.18 To-
gether, this method can be used for both discovery and quanti-
fication of oxylipins and FAs in biological samples. The ap-
proach is here demonstrated on human thrombin activated 
platelets and Salmonella enterica serovar Typhimurium in-
fected murine bone-marrow derived macrophages (BMDMs). 
MATERIALS AND METHODS 
Materials. Lipid standards were purchased from Santa Cruz 
Biotechnology (Heidelberg, Germany) or Cayman Chemical 
(supplied by Cambridge Bioscience, Cambridge, UK). All sol-
vents were Chromasolv LC-MS grade from Honeywell. Ul-
trapure LPS from Escherichia coli O111:B4 was from Invi-
voGen. All other reagents were purchased from Sigma Aldrich 
(Merck KGaA, Darmstadt, Germany) unless otherwise stated. 
Mice. Wild type C57BL/6 mice were obtained from Charles 
River, UK. All animals were housed under specific pathogen-
free conditions and all work involving live animals complied 
with the University of Cambridge Ethics Committee regulations 
under Home Office Project License number 80/2572. 
Cell isolation and culture. BMDMs were retrieved from the 
bone marrow of legs of wild type C57BL/6 mice and cultured 
in BMDM growth media (Dulbecco’s modified Eagle’s me-
dium supplemented with 10% fetal bovine serum, 20% L929 
conditioned media and 5 mM L-glutamine). After centrifuga-
tion, both isolated cells and medium were divided into 2 groups 
to subject only one of them to infection with a solution of S. 
Typhimurium strain SL1344 in BMDM growth media with 
multiplicity of infection equal to 1. This resulted in 4 classes of 
samples: infected and uninfected cells, and infected and unin-
fected medium (see Supporting Materials for further details). 
Thrombin stimulation of isolated human platelets. All ex-
periments were performed in accordance with the Cambridge 
Human Biology Research Ethics Committee; informed consent 
was obtained from donors as applicable, according to the Dec-
laration of Helsinki. Platelets from three donors were isolated 
and activated using 0.2 U/mL thrombin as described previ-
ously19 (see Supporting Materials for further details). Platelets 
were divided in 4 groups and differently treated with thrombin, 
aspirin, ethanol, or untreated.   
Lipid extraction. Chilled 2.5 mL isopropanol/hexane/acetic 
acid extraction solution (20:30:2, v/v/v) and 10 ng internal 
standard (added as 1 ng/µL methanol solution, PGE2-d4, 12-
HETE-d8, and arachidonic acid-d8 for platelet experiments, or 
deuterated primary COX & LOX LC-MS mixture CAY19228-
1 for BMDM experiments) were added to 1 mL isolated plate-
lets, cells, or cell culture media and kept on ice for 10 min. Sam-
ples were vortexed, 2.5 mL of chilled hexane added, and vor-
texed again. The organic layer was recovered after centrifuga-
tion for 5 min at 4oC at 900 g, while the remaining portion of 
the samples were re-extracted by addition of an equal volume 
of hexane. The aqueous layer was subjected to a modified Bligh 
& Dyer extraction. Briefly, 3.75 mL chloroform:methanol (1:2, 
v/v) were added to the aqueous layer, samples were vortexed 
and 1.25 mL chloroform added. Following vortexing, 1.25 mL 
water was added, samples were vortexed again and centrifuged 
at 4oC at 900 g for 5 min. The organic layer was combined with 
lipid extracts from the first extraction step, dried under nitrogen 
gas, resuspended in 100 µL of methanol and analyzed by LC-
DTIM-MS. 
LC-DTIM-MS analysis. 5 μL of lipid extract was analyzed 
using an Infinity II UHPLC coupled to an Agilent 6560 IM 
QTOF MS (Agilent Technologies, Santa Clara, USA) using a 
reversed-phase ACQUITY CSH C18 column (1.7 μm, 2.1x100 
mm, Waters, UK), which was held at 45°C during analysis.. LC 
separation was adapted from Ostermann et al.7 Briefly, the 
UHPLC was operated at a flow rate of 0.5 mL/min using wa-
ter/solvent B (95%/5%) with 0.1% glacial acetic acid as solvent 
A and acetonitrile/methanol/glacial acetic acid (800/150/1, 
v/v/v) as solvent B. Solvent B was increased from 30 % at 0-1 
min to 35 % at 4 min, 67.5 % at 12.5 min, and 100 % at 17.5 
min. Following a 3.5 min of isocratic elution at 100 % solvent 
B, the column was re-equilibrated for 2.5 min at 30 % solvent 
B.20 A flow rate of 0.3 mL/min (50% solvent B) was used for 
flow injection experiments. Lipids were analyzed in negative 
IM-QTOF mode in the m/z range of 100-1000 and maximum 
drift time (DT) of 60 ms using nitrogen as drift gas, a trap fill 
time of 25 ms, trap release time of 0.5 ms and acquisition rate 
of 1 IM  frame/s. An Agilent tuning solution was injected both 
before the analysis to tune the instrument in the m/z range 100-
1700, and every 10 samples to perform DTCCSN2 re-calibration. 
An Agilent reference mix for mass re-calibration was continu-
ously injected alongside the samples using the secondary 
sprayer. The Dual Agilent Jet Stream electrospray ionization 
source was operated at gas temperature of 325oC, drying gas 5 
L/min, sheath gas temperature of 275oC and a sheath gas flow 
of 12 L/min.  A drift gas upgrade kit maintained both drift tube 
and trap funnel pressure constant at 3.9 and 3.8 Torr respec-
tively, while drift tube temperature was found to be stable at 
23.5oC ± 0.3oC across all acquisition runs. Fragmentation with 
alternating frames was used for data-independent acquisition 
(IM-MS/MS) of pooled samples (QCs), with the collision en-
ergy of frame two fixed at 30V. 
Creation of an Internal Database of Oxylipins. An internal 
database containing accurate mass, retention time (RT) and 
DTCCSN2 values was obtained for 47 lipid standards previously 
acquired in triplicates across different days using the instrumen-
tal, analytical and pre-processing method described. This data 
was further processed with an in-house pipeline based on the 
KNIME Analytics Platform21 to build a database containing 
[M-H]-, [M-H+CH3CO2Na]-, [2M-2H+Na]- and [2M-H]- spe-
cies (Table S1 and https://github.com/sonial/KniMet). First, a 
list containing lipid standard names, exact molecular weight, 
expected RT (manually inferred from previous acquisitions), 
SMILES, formula and InChI was created with the aid of the 
ChemAxon22 and RDKit23 KNIME nodes. This list was used to 
annotate the individual acquisitions based on accurate mass and 
RT match (error ranges 10 ppm and 0.15 min, respectively) with 
an adapted version of the KniMet functionality “Feature Anno-
tation”, which was modified to take into account also RT range. 
 A subsequent cleaning of the annotations consisted of keeping 
only the features annotated as different adducts of the same 
molecule within a RT range of ± 0.01 min from a [M-H]- con-
former. This allows one to keep only co-eluting adducts and 
eliminate erroneous annotations derived from the large RT 
range required for the annotation step. The results obtained for 
each different acquisition were then merged in the database if 
they were present in at least two out of three injections with a 
relative standard deviation (RSD) smaller than 1% for m/z and 
1.5% for both RT and DTCCSN2. This results in five peaks on 
average per lipid, with some of them deriving from the same 
adduct suggesting either different conformations or more com-
plex ion arrangements (discussed in the section “Ion mobility 
allows identification of lipid clusters”). 
Data processing. Data pre-processing, including mass and 
DTCCSN2 re-calibration and feature finding, was carried out us-
ing the packages IM-MS Reprocessor, IM-MS Browser and 
Mass Profiler from the MassHunter Suite (version B.08.00, Ag-
ilent Technologies, Santa Clara, USA). In particular, CCS cali-
bration was performed in batches containing 10 samples and 
one calibrant, where the slope and intercept (β and TFix in IM-
MS Browser) values obtained for the DT correction of the cali-
brant were applied to samples for calculation of DTCCSN2 
(please refer to 24 and 25 for more details of CCS calibration in 
DTIM). Stability of the calibration was assessed by calculating 
the CCS for a dummy feature (DT = 28 and m/z = 313, which 
are the average values found in our internal database) using the 
β and TFix values obtained from the several calibrant infusions, 
with RSD equal 0.097% for the 4 calibrants infused in BMDM 
and 0.103% for the 5 calibrants infused in the platelets study. 
Feature finding was performed for signals having a minimum 
ion count of 100 using the maximum ion volume as a measure 
of abundance and an isotopic model designed for common or-
ganic molecules without halogen atoms. Moreover, only spe-
cies with charge state = 1-2 were extracted, including single ion 
features with charge state = 1. Features were aligned if they fell 
within the confidence intervals of 10 ppm ± 3 mDa in m/z and 
in 0.3 min in RT. Furthermore, an m/z range (199-1000) was 
selected to include monomers, dimers and adducts. A final filter 
based on Q-Score (greater than 60 on a scale of 0-100; value 
obtained from Mass Profiler, provides an indication about data 
quality considering parameters such as isotopic pattern), DT 
(15-35 ms), and RT (0.9-20 min) or detection window (0-0.5 
min) for flow injection experiments was applied. Quantification 
was performed using the Agilent MassHunter Quantitative 
Analysis software. Although the input files contained IM data, 
the software simply ignores the IM dimension and quantifies 
based on the chromatographic peak. Lipid levels were normal-
ized to internal standard levels. On the other hand, an adaptation 
of the KniMet pipeline for MS-based metabolomics data pro-
cessing15 was used to perform profiling of oxylipins. More spe-
cifically, features were retained if they were found in at least 
70% of the samples belonging to a class with an average abun-
dance higher than 5000. This first filtering of noise was final-
ized by the removal of all features whose average intensity in 
samples was less than twice the average intensity in uninfected 
medium samples in the BMDM experiment, while periodic in-
jections of a dilution series of quality control samples (QCs, ob-
tained pooling all samples analyzed) was used in the platelets 
experiment to remove features whose intensity does not vary 
linearly with concentration of the sample (node “QC dilution 
series-based Features Filtering” added to KniMet). The remain-
ing features were then subjected to missing value imputation 
using k-nearest neighbor for multivariate statistical analysis, 
while replacement of missing values with half of the minimum 
value found in each sample was used for univariate analysis to 
avoid a possible change of the data distribution.26 Finally, sig-
nals were normalized using probabilistic quotient normalization 
based on all samples27 and logarithmic transformed. Identifica-
tion of oxylipins and FAs was performed by accurate mass, RT 
and DTCCSN2 match with the internal database, with error ranges 
of 10 ppm for mass accuracy, 0.15 min for RT difference and 
2% RSD for DTCCSN2. Moreover, lipid-like flags were added: 
features presenting m/z and RT within the aforementioned 
ranges, but different DTCCSN2 values from those present in the 
database, were flagged as possible new conformers, while fea-
tures with m/z and DTCCSN2 within these ranges but different RT 
were flagged as possible new compounds. Annotation of lipids 
not present in our internal database was performed by compar-
ison with a subset of the LMSD (version updated in 12/2016)16 
containing only lipids belonging to the fatty acyl class (to which 
oxylipins belong).28 In both annotation and identification steps, 
species whose RT is further than 0.01 min from the relative [M-
H]- were removed to eliminate wrongly annotated dimers and 
adducts. Both annotations were performed by adapting the 
“Feature Annotation” functionality of KniMet. In particular, 
“Feature Annotation from internal IMS DB” was added to 
KniMet to allow annotation based also on DTCCSN2 match and, 
if available, RT, to flag lipid-like compounds, and to remove 
dimers with no monomers in a given RT range. Similarly, the 
"Feature Annotation - Internal2external” functionality performs 
annotation on a specific class of LIPID MAPS and removes di-
mers with no monomers in a given RT range (all created 
KniMet nodes available at https://github.com/sonial/KniMet). 
Principal Component Analysis (PCA) was performed using 
SIMCA (Umetrics, Sweden), while heatmap representations 
were created using the function heatmap.2, part of the gplots29 
library of R,30 with default parameters for both hierarchical 
clustering and dissimilarity calculation. 
RESULTS AND DISCUSSION 
Acquisition and data processing workflow for oxylipin 
and fatty acid analysis. Oxylipins are a class of lipids present-
ing strong structural similarities, but their polarity can vary de-
pending on number of oxygen atoms, position of hydroxyl 
groups or number of double bonds. Therefore, a reversed-phase 
gradient method20 was used to separate oxylipins and FAs in the 
first dimension (Figure S2) prior to further separation by IM and 
accurate mass detection by QTOF MS. To profile the lipid con-
tent, features picked by Mass Profiler were processed using 
KniMet to perform data normalization, feature filtering, identi-
fication and annotation. For feature identification, an in-house 
lipid library (Table S1) was used. Features not present in the 
library were putatively annotated based on accurate mass using 
LMSD. In addition to lipid discovery, lipids were quantified us-
ing the Quantitative Analysis software if a standard curve was 
analyzed alongside. To confirm lipid identities, either a QC or 
a known sample containing oxylipins (if concentration in the 
QC was too low) was analyzed using data-independent acquisi-
tion, which does not require the long development time of tar-
geted methods. Due to fragmentation taking place after the drift 
tube, product ions time-align to their precursors, allowing iden-
tification of diagnostic product ions9 and conferring more con-
fidence in oxylipin identification.  
 Ion mobility allows identification of lipid clusters. DTIM 
separation can be visualized in drift spectra, in which counts are 
plotted versus DT (ms), and driftograms, where instead DT is 
plotted against m/z. Multiple drift peaks were observed for all 
lipids analyzed in this study, with one of these peaks being dom-
inant in intensity and hence corresponding to the most stable 
conformer in the gas phase. DTIM-MS analysis of the most 
abundant [M-H]- (referred to as species 1) conformer of ox-
ylipins and FAs shows that they occupy both tight DTCCSN2 and 
mass ranges (CCS = 174-221 Å2, m/z = 296-496 for the former; 
CCS = 158-185 Å2, m/z = 200-328 for the latter). However, the 
driftograms produced by most lipids suggest the presence of 
multiple conformations, with several features having identical 
RT and m/z but different DT. Among these, low abundant spe-
cies drifting in close proximity to the dominant peak were 
found, which could derive from either different isomers (geo-
metric- or stereo-isomers) or different conformers of species 
1.24 In contrast, the second most intense signal corresponds to a 
feature (species 2) drifting about 10 ms later than species 1. Alt-
hough differences in DTCCSN2 values, corresponding to differ-
ent conformations, have been previously described for FAs,24 
the
 
DT differences observed between species 1 and 2 (Table S1) 
may be too great to correspond to different conformers. The ap-
pearance of species 2 depends on the concentration of both lipid 
and organic solvent used, which was tested under six different 
conditions for PGE2 (Figure 1Figure 1 A), arachidonic acid, 12-
HETE and 5(6)-EET (Figure S3). Although the intensity of spe-
cies 2 increased with an increase in the organic solvent content, 
the relationship is not linear and may also depend on the polar-
ity and solubility of the individual lipid (Figure S4). Along with 
[M-H]- of species 2, co-drifting (± 0.5 ms) [2M-H]- and [2M-
2H+Na]- ions were detected as well (Figure 1Figure 1 B). To 
identify both dimers and species 2, we undertook targeted frag-
mentation of all species, namely [M-H]-, [2M-H]- (Figure 
1Figure 1 C and D), [M-H+CH3CO2Na]- [2M-2H+Na]-, [M-H-
H2O]-, [M-H-2H2O]-. This led to diagnostic product ions m/z 
271.2064 and m/z 189.1289 (Figure S5), which DT-align (± 0.5 
ms) with their precursor ions (Figure 1Figure 1 C-D). Compa-
rable results were also obtained when applying data-independ-
ent fragmentation (Figure 1Figure 1 E-F), demonstrating that 
diagnostic product ions derive from monomers, adducts, and di-
mers. Therefore, we propose that species 2 are product ions de-
rived from lipid dimers, which are formed before IM separation 
and partly dissociate after the IM cell prior to mass detection. 
This would explain their detection as m/z corresponding to [M-
H]- species but co-drifting with lipid dimers. Indeed, using the 
Agilent 6560 DTIM-MS, ions are focussed by a high-pressure 
ion funnel and accumulated by an ion trap prior to be released 
into the drift tube. When ions leave the drift tube, they are refo-
cussed by a rear ion funnel, followed by m/z detection in the 
QTOF. These focussing and trapping procedures could result in 
the formation of unstable ion clusters such as dimers and sol-
vent clusters, which partly fall apart before m/z detection and 
cause the aforementioned peaks with different DTs. We tested 
this hypothesis by altering trap fill time (20 or 30 ms) and low-
ering trap funnel RF voltages (-150V, -100V, -76V), but the 
signals remained the same (Figure S6), suggesting that more 
complex ion arrangements may occur during analysis. Simi-
larly, the described ion species were present using different 
source conditions, including higher temperatures (data not 
shown).  In addition, [M-H+CH3CO2Na]- species were ob-
served, but these species drift independently from monomers 
and dimers (Figure 1Figure 1 E, Figure S3 B, D and F, red) due 
Figure 1: DTIM allows separation of adducts and alignment of pre-
cursor and product ions following fragmentation. (A) PGE2 stand-
ard was analyzed by flow injection DTIM-MS using varying con-
centrations of acetonitrile:methanol. The intensity of the two most 
abundant [M-H]- conformer is plotted versus the DT and the con-
centration of organic solvent (average DTs in green). (B) Drift 
spectra for the conformers [M-H]- (black), [M-H+CH3CO2Na]- 
(red), [2M-H]- (green) and [2M-2H+Na]- (purple). (C) Targeted 
DTIM-MS/MS analysis of the [M-H]- species (black) enables drift-
time alignment with the diagnostic product ions m/z 271.2064 (yel-
low) and m/z 189.1285 (light blue). (D) Similarly, fragmentation of 
[2M-H]- (green) results in product ions m/z 271.2064, m/z 
189.1285, as well as water loss products [M-H-H2O]- (dashed 
green) and [M-H-2H2O]- (dashed pink) co-drifting with their pre-
cursor at 33.4 ms. Product ion peaks are magnified by factor 2. 
Data-independent acquisition (DIA) gives similar results, with 
product ions m/z 271.2064 and m/z 189.1285 as well as species [M-
H-H2O]- and [M-H-2H2O]- time-aligning to their precursor ions 
[M-H]-, [2M-H]-, [M-H+CH3CO2Na]- (red), and [2M-2H+Na]- 
(purple). (E, F). The driftogram obtained from DIA (G) highlights 
how water-loss products deriving from both species 1 at 23.4 ms 
and 2 at 32.9 ms can be products (red, high fragmentation) and pre-
cursors (green, low fragmentation). 
 to their different m/z. Moreover, using altering high/low frag-
mentation with DTIM it was observed that the [M-H-H2O]- and 
[M-H-2H2O]- species are not only products but also precursors 
ions, suggesting that some [M-H]- precursors lose a water mol-
ecule before fragmentation (Figure 1Figure 1 G). Note, this may 
not be an in-source fragmentation as modifying source parame-
ters did not remove these species (data not shown). Further dis-
cussions to identification of unspecific losses using DTIM can 
be found in Supporting Discussion. On the other hand, for-
mation of sodium acetate adducts increases with increasing or-
ganic solvent content (Figure S4 C), as expected given the en-
hanced concentration of acetic acid in the solution. However, 
this does not apply to dimers (Figure S4 B and D), indicating 
that dimer formation occurs following ionization. 
In addition to our observation using lipid standards and flow 
injection DTIM-MS, we also observed lipid dimers and solvent 
adducts using both LC-DTIM-MS analysis of lipid standards 
and biological samples and flow injection MS analysis of lipid 
standards using a triple quadrupole instrument in Q1 scan mode 
(Figure S7). Therefore, using LC-DTIM-MS allowed additional 
information regarding lipid cluster formation, which may also 
take place on other instruments but could potentially be over-
looked.  
The level of unsaturation changes the drift peak shape of 
fatty acids. In addition to oxylipins, free FAs can be analyzed 
using our method. As previously shown,9,31 DT increases with 
both chain length and degree of saturation (Figure S8). The 
shape of the drift peak changes with the degree of saturation, as 
shown for a series of FAs with 18 carbon atoms in their chain 
and an increasing number of double bonds (Figure 2). The drift 
spectra of saturated C18:0, as well as the unsaturated species 
C18:1 C18:2, contain two peaks. In contrast, the drift spectra of 
poly-unsaturated C18:3 and C18:4 contain one tailing peak 
which possibly covers the equivalent to the second peak de-
tected in C18:0, C18:1 and C18:2. Drift peak tailing suggests 
multiple molecular conformations of the ions, possibly due to 
the higher degree of unsaturation. This hypothesis finds confir-
mation in the recent work of Stow and co-workers, who de-
scribed an increasing number of theoretical DTCCSN2 values for 
fatty acid conformers with different levels of unsaturation.24 
Presence of multiple conformers does not affect comparability 
of DTCCSN2 values between different studies and laboratories, 
as the most abundant ones (and therefore the most stable con-
formers) can be used for comparison. However, as isomers are 
expected to drift close to the original conformer,31 peak tailing 
should be taken into consideration when investigating isomer 
formation, for example under certain biological conditions such 
as oxidative stress where non-enzymatic autoxidation may lead 
to the formation of isomers not normally observed.  
HETE-esterified phosphatidylcholines show a distinct 
mobility behavior. Eicosanoids not only act as free lipid medi-
ators released by cells, but can also be re-esterified into phos-
pholipids.6 To explore the DTIM behavior of eicosanoid-ester-
ified phospholipids, we analyzed 8-, 9-, 11-, 12-, and 15-HETE-
esterified phosphatidylcholines (PC) using flow injection 
DTIM-MS. Separation of the different HETE-PCs by DTIM de-
pends on the ion type analyzed, with [M+OAc]- species present-
ing the greatest separation between structural isomers, followed 
by sodiated species, and finally protonated ions with the lowest 
drift separation (Error! Reference source not found.Figure 3). 
In addition, drift separation of acetate adducts demonstrated 
that a hydroxyl group close to the PC headgroup (such as in 8- 
and 9-HETE) results in faster mobility perhaps due to a smaller 
molecular size than that conferred by hydroxyl groups further 
away from the headgroup (12- and 15-HETE). The same differ-
ence in mobility, but to a smaller extent, can also be observed 
for the sodiated adducts. Therefore, we propose that both ace-
tate and sodium interact with the hydroxyl group of the esteri-
fied HETE, resulting in a rather rigid structure of the molecule 
and distinct mobility behaviors. Although these phospholipids 
separate in LC,32 and baseline separation of different isomers by 
DTIM could not be achieved, our findings are in agreement with 
previous observations9 and show the potential to identify these 
isomeric lipids in complex samples based on DTCCSN2 values 
using a higher IM resolving power. 
 Quantification of oxylipins and fatty acids in S. Typhi-
murium activated murine BMDMs and thrombin activated 
human platelets. Eicosanoids are one of the least abundant li-
pid species found in cells and tissues, however, they are gener-
ated rapidly in response to acute cell activation during inflam-
matory processes or thrombus formation. As absolute quantities 
Figure 2: Drift spectra of C18 fatty acids differing in the number of 
double bonds: the second peak gets included in the tail of the first 
(most abundant) peak with increasing number of double bonds in 
the acyl chain.   
Figure 3: Separation of eicosanoid-esterified phosphatidylcholines 
by DTIM-MS depends on both position of the hydroxyl group and 
adduct type. DTIM-MS analysis in both positive and negative 
mode of 8-, 9-, 11-, 12-, and 15-HETE esterified PCs (structures 
shown in D) shows enhanced separation between these isomers for 
[M+OAc]- conformers (A) compared to sodium adducts (C), while 
[M+H]+ species (B) are not distinguishable in drift space. 
 of oxylipins are important in many studies, we developed a 
workflow which can be used for both profiling and quantifica-
tion. A calibration curve containing increasing amounts of 16 
lipid standards as well as steady amounts of 6 deuterated ana-
logues (Table S2) was generated. The lower limit of quantifica-
tion (LLOQ) was defined as the amount of lipid required to 
achieve a signal-to-noise ratio greater than 9. Three deuterated 
standards (PGE2-d4, arachidonic acid-d8, and 12-HETE-d8) cov-
ering both oxylipins and FAs as well as different polarities, 
were spiked into platelet samples before lipid extraction to de-
termine complete recovery rates, which were found to be 74% 
for PGE2-d4, 87% for arachidonic acid-d8 and 91% for 12-
HETE-d8. This indicates low matrix and ionization effects on 
our approach. Lipid concentrations in samples were calculated 
using an external calibration curve and internal standards spiked 
into the samples before lipid extraction to account for both ma-
trix effects and losses during the extraction procedure. The 
LLOQs ranged between 2 and 20 pg on column, equivalent to 
0.6 and 11.3 nM, and regression coefficients R2> 0.98 were 
achieved (Figure S9, Table S2). To confirm lipid annotation 
from KniMet, both RTs and product ion spectra were compared 
to either lipid standards or spectra published on LIPID MAPS. 
Among the 16 compounds included in the calibration curve, 
seven were identified and quantified in BMDMs, with their con-
centration levels found to be in the low nanogram range per 
5x106 cells (Figure 4Figure 4, A, Table S3) as previously re-
ported upon S. Typhimurium infection.33 Similarly, quantifica-
tion of PGE2, 12-HETE and arachidonic acid in thrombin acti-
vated human platelets (Figure 4Figure 4 B) agrees with the re-
sults of similar studies.19,34,35 Moreover, simultaneous treatment 
of platelets with thrombin and the COX inhibitor aspirin re-
sulted in decreased prostanoid levels. In contrast, 12-HETE, 
which is the most abundant oxylipin amongst those quantified, 
was increased following both treatment with thrombin and a 
combination of thrombin and aspirin. This is possibly due to 
more arachidonic acid being available and therefore a higher 
turnover rate of 12-LOX. Indeed, aspirin treatment resulted in 
enrichment of arachidonic acid in the platelets, as a conse-
quence of one oxylipin pathway (COX) being inhibited. There-
fore, these results demonstrate that our quantification method 
not only reaches low oxylipin levels, but also covers the wide 
dynamic range required for oxylipin analysis in biological sam-
ples.  
Profiling of oxylipins in biological samples. Although re-
search around oxylipins, especially eicosanoids, emerged in the 
1960 after the discovery of their generating enzymes, several 
members of this lipid class were only characterized in more re-
cent years19,36–38 with many oxylipins possibly still remaining 
unknown. Hence, we developed a profiling UHPLC-DTIM-MS 
workflow to investigate oxylipin generation, exemplarily 
shown on S. Typhimurium infected murine BMDMs and throm-
bin activated human platelets. A three-level annotation was im-
plemented, with features (i) identified by accurate mass, RT and 
DTCCSN2 match with the internal database, (ii) annotated based 
on accurate mass match with LMSD, or (iii) flagged as “lipid-
like” features. Features were classified as lipid-like if present-
ing identical accurate mass but differing on either RT or 
DTCCSN2 values from the compounds in the database. More spe-
cifically, lipid-like features can be oxylipin category-like (e.g. 
prostaglandin (PG)-like) if their accurate mass and DTCCSN2 
values fall within the annotation thresholds but their RT does 
not, hence indicating a possible new compound with different 
polarity within the lipid class. This is illustrated in thrombin ac-
tivated platelets on the extracted ion chromatogram for m/z 
351.2177, which corresponds to a number of different ox-
ylipins, including PGE2 (Figure 5 F, G). On the other hand, if a 
compound is detected with accurate mass and RT comparable 
to those of the lipid standard but different DTCCSN2 value, it is 
flagged as specific lipid-like (e.g. PGF2α-like). The latter is 
based on the assumption that structurally similar lipids have a 
similar “drift-fingerprint”, i.e. a similar distribution of species 
with identical m/z and RT, but different DT. Hence, the discov-
ery of a feature in a biological sample whose m/z and RT fall 
within the ranges of a standard, but DTCCSN2 does not, might 
represent a new isomer of the molecule. These oxylipin cate-
gory-like or specific lipid-like flags give one more confidence 
in identifying new compounds or new conformers not present 
in the internal database than using solely accurate mass match 
with an external library, which commonly results in multiple 
putative annotations for the same feature.   
Using this protocol on the BMDMs data, out of 3339 features 
we standard-identified 85 species, flagged 146 as lipid-like, and 
putatively annotated with LIPID MAPS 624 features, while 
2484 features remained unknown (Table S4 and Figure S10 A). 
Figure 4: Quantification of oxylipins and fatty acids in S. Typhi-
murium infected murine BMDMs and thrombin activated human 
platelets analyzed by UHPLC/DTIM-MS. (A) Lipids included in 
the calibration curve were quantified in BMDMs, indicating an in-
crease of most species following infection with S. Typhimurium. 
(B) PGE2, 12-HETE, and arachidonic acid were quantified in plate-
lets. PGE2 levels increased following treatment with thrombin, 
while its formation was inhibited by treatment with aspirin. On the 
other hand, both 12-HETE and arachidonic acid levels significantly 
increased following both thrombin alone and thrombin and aspirin 
treatment. Bar plots are created utilizing mean values ± standard 
error of the mean, * p < 0.05, ** p < 0.005, *** p < 0.0005 (Stu-
dent’s t-test (BMDMs) or one-way ANOVA followed by Bonfer-
roni correction (platelets). 
 Our findings agree with previous results showing that infection 
with S. Typhimurium induces eicosanoid production in 
BMDMs.33 Among the identified lipids differentiating between 
infected and uninfected samples were known mediators of in-
flammation, such as PGE2 and 5-HETE, (Figure S11, Table S5). 
The high number of unknown features is due to (i) the accurate 
mass range of m/z 199-1000 used for feature extraction, which 
was chosen to include lipid dimers and adducts but might have 
led to the addition of features not corresponding to oxylipins; 
(ii) the limited size of our internal database, as well as the rela-
tively low number of oxylipins present in the LMSD. Nonethe-
less, it has to be taken into consideration that each lipid charac-
terized contains on average 5 drift peaks (discussed above), 
which play an important role on the overall high number of fea-
tures. Considering a tighter m/z range comprising only the [M-
H]- species of FAs and oxylipins present in our database (200-
500), the number of features reduces to 2595 with 1775 un-
knowns. However, information about dimers and cluster for-
mation would be lost using this mass range. On the other hand, 
data processing ignoring the mobility dimension yields 580 fea-
tures, out of which only 177 are annotated with the fatty acyl 
portion of LMSD (Supporting Discussion, Figure S12). This 
noticeable reduction of annotated features further highlights the 
importance of IM in gaining new insights into LC-MS analysis 
of lipids. The high abundancy of features found using IM might 
raise concerns about ion formation in the source, ion movement 
in the drift tube or feature finding algorithms. As described 
above, we tested the consistency of features found across mul-
tiple injections, as well as their changing abundancy dependent 
on either sample concentration or solvent composition, and the 
results suggest that their presence is not triggered by instrument 
settings or data processing algorithms but that the features de-
tected by DTIM are present in the sample. 
Our oxylipins and FAs profiling method was further tested 
on human platelets isolated from three donors treated with the 
pro-coagulant thrombin to trigger oxylipin generation.39,40 Sta-
tistical analysis of the data processed with KniMet revealed dif-
ferences between treatment groups (Figure 5, Figure S13 and 
Table S6), which are in agreement with previous findings.39,40 
Out of the 2591 features remaining after filtering, 57 were iden-
tified by the internal library of standards, 109 were flagged as 
lipid-like, and 433 could only be annotated with LMSD, while 
1992 remained unidentified (Table S7, Figure S10 B). Although 
putative annotation results in multiple possible identities, the 
combination of lipid-like flagging, annotation from the external 
database and finally data-independent acquisition in IM-
MS/MS mode allows lipid identification, as exemplified by the 
identification of Thromboxane B2 (TxB2, Figure 5 C-E): the fea-
ture presenting m/z = 369.2270, RT = 3.33 min and DT = 23.89 
ms was flagged as PG-like [M-H]- by the internal annotation 
system and putatively annotated by LMSD as 10,11-dihydro-
20-dihydroxy-LTB4, 19-hydroxy-PGE1, 19-hydroxy-PGF2α, 
20-hydroxy-PGF2α, and TxB2 (Table S7). Alignment in DT be-
tween precursor and product ions allowed identification as 
TxB2 (Figure 5 E) and confirmed our strategy of flagging com-
pounds as structural similar to those in the internal database 
based on their chromatography and mobility characteristics. On 
the other hand, features flagged as new compounds are identical 
in m/z and similar in DTCCSN2 but differ in RT, as illustrated on 
m/z 351.2177 (Figure 5 F, G).  
Conclusion. In this study we present a comprehensive LC-
DTIM-MS method for both profiling and quantification of ox-
ylipins and their precursors FAs in biological samples. Using 
replicate acquisitions of lipid standards across different days, an 
average RSD of 0.19%, 0.21%, 0.20% and 0.18% for the 
DTCCSN2 of the species [M-H]-, [M-H+CH3CO2Na]-, [2M-H]- 
and [2M-2H+Na]- respectively, was obtained (Table S1). Fur-
ther confirmation of the validity of our measurements comes 
from comparison with CCS values in the literature.12,14,24 This 
results in an average RSD below 2% (Table S8), which is the 
accepted error threshold for intra-lab CCS measurements. How-
ever, several species are found above this value, with the strong-
est outlier being lauric acid (RSD = 5.59%). Nonetheless, in-
house triplicate acquisitions of lauric acid resulted in highly re-
peatable measurements (RSD = 0.013-0.466, table S1). This 
high variability with the CCS reported in the literature could 
derive from a number of sources of uncertainty, including dif-
ferences in the analytical details, which must be taken into con-
sideration when building CCS libraries on standards and/or lit-
erature values if not enough experimental or computationally 
generated CCS information exists for comparison. However, 
the low internal RSDs allowed us to use DTCCSN2 in addition to 
Figure 5: The changes in the oxylipin profile induced by thrombin 
treatment of human isolated platelets can be identified using 
MS/MS spectra and DT alignment of product and precursor ions. 
(A) Score plot of the principal component analysis (first versus sec-
ond PC) of lipid extracts of isolated human platelets analyzed by 
LC/DTIM-MS and processed with KniMet. The four treatment 
groups are: thrombin plus aspirin (green), thrombin (blue), throm-
bin plus ethanol (yellow) and untreated (red). (B) Heatmap repre-
sentation and hierarchical clustering of the distance matrix between 
samples in the four treatments. Separation between treatment 
groups can be observed, with three distinct clusters (aspirin, control 
and ethanol/thrombin) in both PCA and heatmap. (C) Full scan at 
3.3 min shows m/z 369.2274, which is putatively annotated as TxB2 
and other oxylipins. (D) Product ion spectrum at 3.3 min shows the 
diagnostic product ions m/z 195.1018 and m/z 169.0864 for TxB2. 
(E) Precursor (black) and product ions (m/z 195.1018 dashed red; 
m/z 169.0864, dashed green) align in DT, confirming the identifi-
cation of the feature as TxB2. Unknown species 1, 2, 3 present iden-
tical m/z, different RT (F) but very similar DT (G) of TxB2, hence 
they are flagged as “lipid-like” features during data annotation. 
 RTs and accurate mass to identify oxylipins and FAs in two sets 
of biological samples. As the CCS value of a compound is a 
physical-chemical parameter and therefore instrument-inde-
pendent, it can be used by others as additional lipid identifiers. 
We showed how DTCCSN2 values in combination with m/z can 
improve the identification process of oxylipins and FAs and al-
lows to flag potential new members of this family. Moreover, 
addition of IM to the workflow allowed separation and identifi-
cation of different lipid conformers, including dimers and sol-
vent clusters, based on DT-alignment of product ions to their 
precursors. In addition, our study highlights the complexity of 
lipid analysis by LC-MS and the necessity of additional ion sep-
aration level to gain further insights into ionization, adduct for-
mation and fragmentation mechanisms. Despite a higher num-
ber of detected features by LC-DTIM-MS compared to LC-MS 
alone, the results presented herein show the potential of this 
technique in simplifying lipid identification by using DTCCSN2 
and DT-alignment of product and precursor ions as additional 
identifiers. To further automate the identification process, diag-
nostic product ions could be added to the library. Moreover, the 
constant improvement of in-silico tools for DTIM data analy-
sis41–43 will allow the combination of our methodology with 
these computational techniques once oxylipins have been inte-
grated in their training set. 
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